Nancy Clark | Health Professions | Women Researcher Award

Posted on by ScienceFather

Assoc. Prof. Dr. Nancy Clark | Health Professions | Women Researcher Award

Nursing at University of Victoria, Canada

Dr. Nancy Clark is a dedicated scholar and researcher in the field of nursing, with a particular focus on addressing social and structural inequities in mental health care for underserved populations. She is currently an Assistant Professor at the University of Victoria, where she engages in teaching, research, and community-based initiatives aimed at promoting health equity. Dr. Clark’s research is rooted in critical theory and intersectionality, emphasizing systemic issues such as racism, classism, and sexism that contribute to social exclusion. Her work has led to meaningful contributions in public policy and healthcare service delivery. As a leader in numerous professional organizations, she collaborates with academic, community, and government partners to enhance the well-being of marginalized groups, particularly immigrants and refugees.

Professional Profile

Education

Dr. Nancy Clark holds a Ph.D. in Nursing from the University of British Columbia (2015), where her dissertation explored community capacity to support Karen refugee women’s mental health during resettlement. She also earned an M.Sc. in Nursing (2005) and a B.Sc. in Nursing (1993) from the same institution. Additionally, she holds a Diploma in Nursing from Langara College (1990). Her academic foundation combines rigorous training in nursing with a focus on mental health and social justice, enabling her to tackle complex healthcare challenges.

Professional Experience

Dr. Clark has over three decades of professional experience in nursing, academia, and community practice. Since 2017, she has served as an Assistant Professor at the University of Victoria, where she teaches and conducts research on mental health equity. Her previous roles include faculty appointments at Vancouver Community College and adjunct positions at the University of British Columbia and Simon Fraser University. Dr. Clark also has extensive experience in clinical practice, having worked in roles such as Community Mental Health Nurse, Case Manager, and Clinical Instructor in mental health and addictions. Her diverse career highlights her expertise in both theoretical and applied aspects of nursing and mental health care.

Research Interests

Dr. Clark’s research focuses on the intersection of mental health, social justice, and public policy, with an emphasis on addressing inequities affecting refugees, immigrants, and other marginalized groups. Her work explores the impact of systemic factors like racism, classism, and sexism on healthcare access and outcomes. She employs qualitative research methods, including ethnography and community-based participatory approaches, to give voice to underserved populations. Her program of research seeks to promote social justice by influencing healthcare policies and practices to recognize and address structural vulnerabilities. She is particularly interested in post-colonial and intersectionality theories, which frame her critical examination of health disparities.

Research Skills

Dr. Clark possesses advanced research skills in qualitative methodologies, including ethnographic and community-based participatory research. Her expertise extends to applying critical theoretical frameworks such as intersectionality and standpoint feminism to investigate systemic inequities in healthcare. She is adept at conducting gender-based policy analyses and translating research findings into actionable policy recommendations. Additionally, her experience in community engagement enables her to design and implement research projects that are both impactful and culturally sensitive, ensuring that marginalized populations have a voice in shaping health services and policies.

Awards and Honors

Dr. Clark’s contributions to nursing and mental health research have earned her numerous accolades and leadership roles. She is a recognized member of several prestigious organizations, including the Health Equity Collaborative Network and the Canadian Association of Schools of Nursing, where she chaired the Mental Health Nurse Educator Group. Her appointment as an Affiliate Researcher at multiple institutions, such as the UBC Centre for Migration Studies and Fraser Health Authority, underscores her influence in the field. Additionally, she has been invited to serve as a Council Member for Pathways to Prosperity Canada, highlighting her commitment to fostering inclusive communities.

Conclusion

Dr. Nancy Clark is a strong candidate for the Best Researcher Award due to her impactful contributions to addressing health inequities among marginalized populations. Her work is rooted in critical theory, social justice, and community engagement, making her research highly relevant and transformative. By expanding her dissemination efforts and emphasizing quantifiable impacts, she could further solidify her position as a leading researcher in the field.

Publication Top Notes

  • Spirituality and treatment choices by South and East Asian women with serious mental illness
    Authors: L Chiu, M Morrow, S Ganesan, N Clark
    Year: 2005
    Citations: 81
  • Pilot study and evaluation of postgraduate course on “the interface between spirituality, religion and psychiatry”
    Authors: A Grabovac, N Clark, M McKenna
    Year: 2008
    Citations: 72
  • Applying intersectionality with constructive grounded theory as an innovative research approach for studying complex populations: Demonstrating congruency
    Authors: S Kassam, L Marcellus, N Clark, J O’Mahony
    Year: 2020
    Citations: 53
  • Religion and spirituality in the context of bipolar disorder: A literature review
    Authors: B Pesut, N Clark, V Maxwell, EE Michalak
    Year: 2011
    Citations: 51
  • Immigrant women and mental health care: Findings from an environmental scan
    Authors: J O’Mahony, N Clark
    Year: 2018
    Citations: 46
  • Exploring community capacity: Karen refugee women’s mental health
    Author: N Clark
    Year: 2018
    Citations: 42
  • Applying critical race feminism and intersectionality to narrative inquiry: A point of resistance for Muslim nurses donning a hijab
    Authors: N Clark, N Saleh
    Year: 2019
    Citations: 39
  • Understanding how self-management interventions work for disadvantaged populations living with chronic conditions: Protocol for a realist synthesis
    Authors: SL Mills, J Pumarino, N Clark, S Carroll, S Dennis, S Koehn, T Yu, …
    Year: 2014
    Citations: 30
  • Exploring intersectionality as a policy tool for gender-based policy analysis: Implications for language and health literacy as key determinants of integration
    Authors: N Clark, B Vissandjée
    Year: 2019
    Citations: 15
  • Themes for evaluating the quality of initiatives to engage patients and family caregivers in decision-making in healthcare systems: A scoping review
    Authors: CB Hamilton, M Dehnadi, ME Snow, N Clark, M Lui, J McLean, …
    Year: 2021
    Citations: 12

 

 

Minji Jung | Health Professions | Best Researcher Award

Posted on by ScienceFather

Dr. Minji Jung | Health Professions | Best Researcher Award

Postdoctoral Scholar at Stanford University Medical Center, United States

Minji Jung is a prominent researcher with expertise in cancer epidemiology, pharmacoepidemiology, and risk factors for chronic diseases such as kidney cancer and cardiovascular conditions. She currently serves as a Postdoctoral Scholar at the Urologic Cancer Epidemiology Lab at Stanford University School of Medicine. Minji has an extensive academic background, earning a PhD in Clinical Pharmacoepidemiology and holding a PharmD degree from Ajou University, South Korea. Her research has spanned multiple high-impact areas, including kidney cancer, cardiovascular diseases, and dementia, with a focus on real-world data analysis. Minji has secured significant research funding, led interdisciplinary projects, and earned numerous awards, underscoring her substantial contributions to health sciences. Her work integrates diverse data sets, cutting-edge statistical methods, and collaborative partnerships, making her a leading figure in her field.

Professional Profile

Education:

Minji Jung holds a PharmD from Ajou University in South Korea, completed in 2016, where she also earned her PhD in Clinical Pharmacoepidemiology in 2021. During her doctoral studies, Minji focused on evaluating the pleiotropic effects of statin therapy, specifically investigating its potential role in preventing hemorrhagic stroke and dementia using Korean nationwide health insurance data. She has further honed her expertise as a Research Fellow at the University of California, San Francisco, in 2021-2022, specializing in pharmacoepidemiology related to cardiovascular disease. Minji’s education has been marked by a strong foundation in clinical pharmacy, epidemiology, and data analytics, laying the groundwork for her current focus on urologic cancer and cardio-oncology research.

Professional Experience:

Minji Jung’s professional journey includes roles in academia and research, where she has made significant strides in clinical pharmacy and epidemiology. She is currently a Postdoctoral Scholar at Stanford University’s Urologic Cancer Epidemiology Lab, where she focuses on cancer epidemiology, pharmacoepidemiology, and kidney cancer research. Previously, she served as a Research Fellow at the University of California, San Francisco, contributing to studies on cardiovascular disease and medication adherence. Minji’s early research experience includes working at Ajou University, South Korea, where she contributed to pharmacoepidemiological projects examining the effects of statin use and its association with stroke and dementia. Her expertise spans across both clinical and epidemiological settings, enabling her to integrate real-world data into her research and offering valuable insights into chronic disease prevention and management.

Research Interests:

Minji Jung’s research interests are centered on cancer epidemiology, pharmacoepidemiology, and the intersection of chronic diseases such as kidney cancer, cardiovascular conditions, and dementia. Her work focuses on understanding the epidemiology and risk factors associated with kidney cancer, analyzing large health data sets to explore connections between metabolic syndrome and cancer incidence. Additionally, Minji is deeply invested in survivorship and psycho-oncology, exploring the mental and physical health outcomes of patients diagnosed with cancer. Her research also delves into cardio-oncology, investigating the cardiovascular risks of cancer patients, especially those undergoing treatment. By using advanced statistical methods and diverse global data sets, Minji aims to improve the prevention, diagnosis, and treatment of chronic diseases, with a focus on kidney cancer and its broader implications for public health.

Research Skills:

Minji Jung possesses advanced research skills, particularly in epidemiological methods, pharmacoepidemiology, and statistical analysis. She is adept at handling large, diverse data sets, such as SEER, UK Biobank, and MarketScan® data, and has expertise in applying a variety of statistical techniques, including logistic regression, survival analysis, propensity score matching, and Cox regression models. Minji is skilled in utilizing real-world data to study the epidemiology of chronic diseases and their interactions with medications. Her proficiency in data analysis is complemented by her ability to integrate findings from multiple disciplines, allowing her to draw meaningful conclusions that influence clinical and public health policies. Minji is also experienced in project management, having led her own research initiatives, and is well-versed in the application of innovative research methods to investigate complex health issues.

Awards and Honors:

Minji Jung has received numerous awards in recognition of her exceptional research contributions. Notably, she was honored with the Poster Award from the Western Section of the American Urological Association in 2024 and was selected as a Notable Scientist by the Korean Biological Research Information Center in 2023. She also won the Oral Presentation Award at the 24th Annual Spring Research Seminar at the University of California, San Francisco, in 2022. Minji’s achievements are further highlighted by an Oral Presentation Award from the Pharmaceutical Society of Korea in 2019, as well as a Certificate of Commendation from the Suwon Pharmaceutical Association in 2018. These accolades reflect the high regard in which she is held by the scientific community, emphasizing her impactful research in the fields of epidemiology and pharmacoepidemiology.

Conclusion

Minji Jung has demonstrated exceptional research capabilities in areas that have profound implications for public health, particularly in cancer epidemiology and pharmacoepidemiology. Her leadership in securing research grants and contributing to significant health-related findings sets her apart as a candidate for the Best Researcher Award. While there are areas that could be further strengthened, particularly in terms of broadening her influence in the public sphere and maximizing publication impact, her accomplishments thus far make her a highly deserving nominee for the award.

Publication Top Notes

  • Effects of statin therapy on the risk of intracerebral hemorrhage in Korean patients with hyperlipidemia
    Authors: M Jung, S Lee
    Year: 2019
    Citations: 22
  • Impact of statin use on dementia incidence in elderly men and women with ischemic heart disease
    Authors: MY Kim, M Jung, Y Noh, S Shin, CH Hong, S Lee, YS Jung
    Year: 2020
    Citations: 18
  • Efficacy of aspirin in the primary prevention of cardiovascular diseases and cancer in the elderly: a population-based cohort study in Korea
    Authors: M Jung, S Lee
    Year: 2020
    Citations: 10
  • Design and evaluation of in vivo bioavailability in beagle dogs of bilayer tablet consisting of immediate release nanosuspension and sustained release layers of rebamipide
    Authors: G Jin, HV Ngo, J Wang, JH Cui, QR Cao, C Park, M Jung, BJ Lee
    Year: 2022
    Citations: 8
  • Comprehensive trends and patterns of antihypertensive prescriptions using a nationwide claims database in Korea
    Authors: M Jung, E Choo, S Lee
    Year: 2020
    Citations: 7
  • Comparing the sensitivities of measures of adherence to antihypertensive drugs using Korean National Health Insurance Claims Data
    Authors: E Choo, M Jung, J Shin, S Lee
    Year: 2021
    Citations: 5
  • Clinical pharmacokinetic study of tacrolimus in continuous intravenous administration for lung transplantation
    Authors: YM Sohn, RE Ko, HJ Park, E Choo, M Jung, S Lee, K Jeon
    Year: 2023
    Citations: 1
  • A comparison of methods for the measurement of adherence to antihypertensive multidrug therapy and the clinical consequences: a retrospective cohort study using the Korean National Health Insurance Claims Data
    Authors: M Jung, E Choo, S Lee
    Year: 2023
    Citations: 1
  • Effects of Postprandial Factors and Second Meal Intake Time on Bioequivalence Investigation of Tadalafil-Loaded Orodispersible Films in Human Volunteers
    Authors: SJ Park, MC Gil, BS Lee, M Jung, BJ Lee
    Year: 2024
    Citations: Not listed yet
  • Air pollution mixture associated with oxidative stress exacerbation and symptoms deterioration in allergic rhinitis patients: Evidence from a panel study
    Authors: J Li, H Wu, W Xing, X Li, Z Han, R Ji, Z Deng, M Jung, S Sun, BI Chung, …
    Year: 2024

 

Marine Gogia | Medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Marine Gogia | Medicine | Best Researcher Award

Program Director at Georgian Harm Reduction Network, Georgia.

Dr. Marine Gogia is a distinguished Public Health Specialist and Patient Advocate with extensive experience in harm reduction and epidemiology. She is currently pursuing a Ph.D. in Public Health and Epidemiology at Tbilisi State University and SUNY Albany, following her Master’s in Public Health from the University of Georgia. Dr. Gogia’s career highlights include her role as Programs Director at the Georgian Harm Reduction Network, where she manages significant projects like the Global Fund initiative targeting HIV/AIDS prevention and harm reduction. Her research encompasses HIV self-testing, hepatitis C treatment, and risk behavior assessments among marginalized groups. Dr. Gogia’s contributions extend to her leadership roles with the European AIDS Treatment Group and various international health organizations. She has been recognized for her impactful research and advocacy, which include numerous publications and presentations at global conferences.

Profile
Education

Dr. Marine Gogia is a highly educated public health specialist with a strong academic background. She is currently pursuing a Ph.D. in Public Health and Epidemiology at Tbilisi State University and SUNY Albany, USA (2022-2025). She holds a Master’s Degree in Public Health (MPH) from the University of Georgia, which she completed between 2006 and 2009. Dr. Gogia’s foundational education was at Tbilisi State Medical University, where she studied Preventive Medicine (1996-2002). Her commitment to continuing education is evident from her participation in specialized courses, including the European Patients Academy (EUPATI) Expert Patients Course (2017-2018) and the EATG Training Academy’s STEP-UP program (2014-2015). This extensive educational background has equipped her with a robust understanding of public health, epidemiology, and the skills necessary to address complex health challenges effectively.

Professional Experience

Dr. Marine Gogia, a distinguished Public Health Specialist and Patient Advocate, has amassed extensive experience in public health, harm reduction, and infectious disease control. Currently a Programs Director at the Georgian Harm Reduction Network (GHRN), she leads critical projects such as the Global Fund initiative to prevent HIV/AIDS and minimize drug-related harm. Her role encompasses both management and research, with notable studies on HIV self-testing and Hepatitis C elimination. Dr. Gogia has also contributed as a Co-chair at the European AIDS Treatment Group (EATG), where she provides technical expertise and strategic direction. Her prior roles include consulting for WHO and the Global Fund, and serving as a Program Coordinator at Curatio International Foundation. Her work reflects a commitment to improving health outcomes and advocating for marginalized communities through rigorous research and strategic program implementation.

Research Interest

Dr. Marine Gogia’s research interests center around public health, with a particular focus on HIV/AIDS, harm reduction, and epidemiology. She is dedicated to advancing strategies for combating HIV and hepatitis C, especially among vulnerable populations such as people who inject drugs (PWID) and marginalized groups. Her work involves evaluating and improving harm reduction programs, assessing risky behaviors, and enhancing access to healthcare services through innovative research methodologies like simplified bio-behavioral surveillance surveys. Dr. Gogia is also actively involved in policy advocacy and capacity building, contributing to global health guidelines and strategies. Her research aims to bridge gaps in healthcare access and improve the effectiveness of public health interventions, with significant contributions to regional and international efforts in infectious disease control and prevention.

Research Skills

Dr. Marine Gogia possesses exceptional research skills demonstrated through her extensive experience in public health and epidemiology. Her expertise includes conducting bio-behavioral surveillance surveys, operational research, and evaluating HIV and hepatitis C testing and treatment programs. Dr. Gogia excels in designing and implementing research methodologies, such as the BSS-Lite survey, to assess risky behaviors among people who inject drugs (PWIDs). She is adept at analyzing data related to HIV self-testing acceptability and identifying barriers to HCV program enrollment. Her research skills are further evident in her contributions to studies on legal and regulatory barriers, and her ability to synthesize complex information into actionable insights for policy-making. Dr. Gogia’s proficiency extends to training and consultancy, where she effectively translates research findings into practical solutions for public health challenges. Her work consistently reflects a high level of analytical rigor and a commitment to advancing public health outcomes.

Awards and Recognition

Maryam has received several certificates of participation and training, including the Training of Trainers certificates, a peer reviewer course, and various certificates in statistical analysis and genetic research. These accolades demonstrate her commitment to continuous learning and professional development.

Conclusion

Maryam Qasim is a promising candidate for the Best Researcher Award due to her significant contributions to antimicrobial resistance research and molecular genetics. Her work, although primarily regional, has the potential to address broader health issues through applied research and collaborative efforts. Her academic background and continued professional development through various certifications further strengthen her candidacy.

Publications Top Notes

  1. Progress Toward the Elimination of Hepatitis B and Hepatitis C in the Country of Georgia, April 2015-April 2024
    • Authors: Tohme, R.A., Shadaker, S., Adamia, E., Schumacher, I.T., Gabunia, T.
    • Year: 2024
  2. Piloting a Simplified Bio-Behavioural Survey Methodology, the BBS-Lite, Among People Who Inject Drugs in Georgia
    • Authors: Gogia, M., Ruadze, E., Kasrashvili, T., Khonelidze, I., Stvilia, K.
    • Year: 2024
  3. Recommendations for Defining Preventable HIV-Related Mortality for Public Health Monitoring in the Era of Getting to Zero: An Expert Consensus
    • Authors: Croxford, S.E., Martin, V., Lucas, S.B., Waters, L.J., Sullivan, A.K.
    • Year: 2023
    • Citations: 1
  4. Barriers of Linkage to HCV Viremia Testing Among People Who Inject Drugs in Georgia
    • Authors: Butsashvili, M., Abzianidze, T., Kamkamidze, G., Nasrullah, M., Averhoff, F.
    • Year: 2022
    • Citations: 2
  5. Hidden Populations: Risk Behaviours in Drug-Using Populations in the Republic of Georgia Through Subsequent Peer-Driven Interventions
    • Authors: Lawlor, C., Gogia, M., Kirtadze, I., Jikia, G., Zurashvili, T.
    • Year: 2021
    • Citations: 1
  6. A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic
    • Authors: Farhoudian, A., Radfar, S.R., Ardabili, H.M., Yitayih, Y., Zhao, M.
    • Year: 2021
    • Citations: 44
  7. Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey
    • Authors: Radfar, S.R., De Jong, C.A.J., Farhoudian, A., Zhao, M., Zonoozi, A.K.
    • Year: 2021
    • Citations: 53
  8. Integration of Hepatitis C Treatment at Harm Reduction Centers in Georgia—Findings from a Patient Satisfaction Survey
    • Authors: Butsashvili, M., Kamkamidze, G., Kajaia, M., Japaridze, M., Averhoff, F.
    • Year: 2020
    • Citations: 9
  9. Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs — Georgia, 2018
    • Authors: Stvilia, K., Spradling, P.R., Asatiani, A., Averhoff, F., Nasrullah, M.
    • Year: 2019
    • Citations: 17
  10. Hidden Populations: Discovering the Differences Between the Known and the Unknown Drug-Using Populations in the Republic of Georgia
    • Authors: Gogia, M., Lawlor, C., Shengelia, N., Stvilia, K., Raymond, H.F.
    • Year: 2019
    • Citations: 1